These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19339358)

  • 1. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
    Wisniewski SR; Rush AJ; Nierenberg AA; Gaynes BN; Warden D; Luther JF; McGrath PJ; Lavori PW; Thase ME; Fava M; Trivedi MH
    Am J Psychiatry; 2009 May; 166(5):599-607. PubMed ID: 19339358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.
    Friedman ES; Wisniewski SR; Gilmer W; Nierenberg AA; Rush AJ; Fava M; Zisook S; Balasubramani GK; Trivedi MH
    Depress Anxiety; 2009; 26(7):612-21. PubMed ID: 19382183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.
    Gilmer WS; Gollan JK; Wisniewski SR; Howland RH; Trivedi MH; Miyahara S; Fleck J; Thase ME; Alpert JE; Nierenberg AA; Warden D; Fava M; Rush AJ
    J Clin Psychiatry; 2008 Aug; 69(8):1246-56. PubMed ID: 18681756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
    Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M;
    Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do atypical features affect outcome in depressed outpatients treated with citalopram?
    Stewart JW; McGrath PJ; Fava M; Wisniewski SR; Zisook S; Cook I; Nierenberg AA; Trivedi MH; Balasubramani GK; Warden D; Lesser I; John Rush A
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):15-30. PubMed ID: 19341509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM; Llorca PM; Despiegel N; Verpillat P
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Income and attrition in the treatment of depression: a STAR*D report.
    Warden D; Rush AJ; Wisniewski SR; Lesser IM; Thase ME; Balasubramani GK; Shores-Wilson K; Nierenberg AA; Trivedi MH
    Depress Anxiety; 2009; 26(7):622-33. PubMed ID: 19582825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes.
    Davis LL; Wisniewski SR; Howland RH; Trivedi MH; Husain MM; Fava M; McGrath PJ; Balasubramani GK; Warden D; Rush AJ
    Drug Alcohol Depend; 2010 Mar; 107(2-3):161-70. PubMed ID: 19945804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
    McGrath PJ; Khan AY; Trivedi MH; Stewart JW; Morris DW; Wisniewski SR; Miyahara S; Nierenberg AA; Fava M; Rush AJ
    J Clin Psychiatry; 2008 Dec; 69(12):1847-55. PubMed ID: 19026268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.
    Zisook S; Trivedi MH; Warden D; Lebowitz B; Thase ME; Stewart JW; Moutier C; Fava M; Wisniewski SR; Luther J; Rush AJ
    J Affect Disord; 2009 Sep; 117(1-2):63-73. PubMed ID: 19217668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
    Kozel FA; Trivedi MH; Wisniewski SR; Miyahara S; Husain MM; Fava M; Lebowitz B; Zisook S; Rush AJ
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):58-64. PubMed ID: 18165462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
    Fava M; Rush AJ; Alpert JE; Balasubramani GK; Wisniewski SR; Carmin CN; Biggs MM; Zisook S; Leuchter A; Howland R; Warden D; Trivedi MH
    Am J Psychiatry; 2008 Mar; 165(3):342-51. PubMed ID: 18172020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.
    Ishak WW; Christensen S; Sayer G; Ha K; Li N; Miller J; Nguyen JM; Cohen RM
    J Clin Psychiatry; 2013 Mar; 74(3):256-61. PubMed ID: 23561231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.
    Warden D; Trivedi MH; Wisniewski SR; Davis L; Nierenberg AA; Gaynes BN; Zisook S; Hollon SD; Balasubramani GK; Howland R; Fava M; Stewart JW; Rush AJ
    Am J Psychiatry; 2007 Aug; 164(8):1189-97. PubMed ID: 17671281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study's patient-level data with fidelity to the original research protocol.
    Pigott HE; Kim T; Xu C; Kirsch I; Amsterdam J
    BMJ Open; 2023 Jul; 13(7):e063095. PubMed ID: 37491091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.
    Gaynes BN; Warden D; Trivedi MH; Wisniewski SR; Fava M; Rush AJ
    Psychiatr Serv; 2009 Nov; 60(11):1439-45. PubMed ID: 19880458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.